280 related articles for article (PubMed ID: 2176165)
1. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
[TBL] [Abstract][Full Text] [Related]
2. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
[TBL] [Abstract][Full Text] [Related]
3. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
[TBL] [Abstract][Full Text] [Related]
4. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
Safrany ST; Sawyer DA; Nahorski SR; Potter BV
Chirality; 1992; 4(7):415-22. PubMed ID: 1334423
[TBL] [Abstract][Full Text] [Related]
5. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
[TBL] [Abstract][Full Text] [Related]
6. 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition.
Safrany ST; Wilcox RA; Liu C; Potter BV; Nahorski SR
Eur J Pharmacol; 1992 Jul; 226(3):265-72. PubMed ID: 1330634
[TBL] [Abstract][Full Text] [Related]
7. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
[TBL] [Abstract][Full Text] [Related]
8. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
Hirata M; Watanabe Y; Yoshida M; Koga T; Ozaki S
J Biol Chem; 1993 Sep; 268(26):19260-6. PubMed ID: 8396130
[TBL] [Abstract][Full Text] [Related]
9. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.
Hansbro PM; Foster PS; Liu C; Potter BV; Denborough MA
Biochem Biophys Res Commun; 1994 Apr; 200(1):8-15. PubMed ID: 8166746
[TBL] [Abstract][Full Text] [Related]
11. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase.
Van Dijken P; Lammers AA; Ozaki S; Potter BV; Erneux C; Van Haastert PJ
Eur J Biochem; 1994 Dec; 226(2):561-6. PubMed ID: 8001571
[TBL] [Abstract][Full Text] [Related]
13. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
[TBL] [Abstract][Full Text] [Related]
14. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase.
Ward SG; Mills SJ; Liu C; Westwick J; Potter BV
J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856
[TBL] [Abstract][Full Text] [Related]
15. The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.
Foster PS; Hogan SP; Hansbro PM; O'Brien R; Potter BV; Ozaki S; Denborough MA
Eur J Biochem; 1994 Jun; 222(3):955-64. PubMed ID: 8026506
[TBL] [Abstract][Full Text] [Related]
16. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
[TBL] [Abstract][Full Text] [Related]
17. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes.
Yoshimura K; Watanabe Y; Erneux C; Hirata M
Cell Signal; 1999 Feb; 11(2):117-25. PubMed ID: 10048789
[TBL] [Abstract][Full Text] [Related]
18. D-myo-inositol 1,4,5-trisphosphate analogues substituted at the 3-hydroxyl group.
Hirata M; Watanabe Y; Kanematsu T; Ozaki S; Koga T
Biochim Biophys Acta; 1995 Jun; 1244(2-3):404-10. PubMed ID: 7599161
[TBL] [Abstract][Full Text] [Related]
19. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
[TBL] [Abstract][Full Text] [Related]
20. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
